Find the latest Tectonic Therapeutic, Inc. (TECX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Jan 30, 2025 · TECX | Complete Tectonic Therapeutic Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

19 hours ago · TECX has been the subject of several analyst reports. Raymond James initiated coverage on Tectonic Therapeutic in a report on Wednesday, November 20th. They issued an "outperform" rating and a $65.00 price objective for the company. Wells Fargo & Company raised their price objective on Tectonic Therapeutic from $79.00 to $112.00 and gave the ...

Tectonic is a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors (GPCRs). Tectonic was co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School.

Get the latest Tectonic Therapeutic Inc (TECX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

5 days ago · See the latest Tectonic Therapeutic Inc stock price (TECX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

View and compare TECX on Yahoo Finance.

4 days ago · Get a real-time Tectonic Therapeutic, Inc. (TECX) stock price quote with breaking news, financials, statistics, charts and more.

Get the latest Tectonic Therapeutic, Inc. (TECX) stock news and headlines to help you in your trading and investing decisions.

5 days ago · A high-level overview of Tectonic Therapeutic, Inc. (TECX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.